These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21882285)

  • 1. Accounting for between-study variation in incremental net benefit in value of information methodology.
    Willan AR; Eckermann S
    Health Econ; 2012 Oct; 21(10):1183-95. PubMed ID: 21882285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining optimal sample sizes for multistage adaptive randomized clinical trials from an industry perspective using value of information methods.
    Chen MH; Willan AR
    Clin Trials; 2013 Feb; 10(1):54-62. PubMed ID: 23263520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.
    Willan A; Kowgier M
    Clin Trials; 2008; 5(4):289-300. PubMed ID: 18697843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal sample size determinations from an industry perspective based on the expected value of information.
    Willan AR
    Clin Trials; 2008; 5(6):587-94. PubMed ID: 19029207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Globally optimal trial design for local decision making.
    Eckermann S; Willan AR
    Health Econ; 2009 Feb; 18(2):203-16. PubMed ID: 18435429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of information methods for planning and analyzing clinical studies optimize decision making and research planning.
    Willan AR; Goeree R; Boutis K
    J Clin Epidemiol; 2012 Aug; 65(8):870-6. PubMed ID: 22609138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental net benefit in randomized clinical trials.
    Willan AR; Lin DY
    Stat Med; 2001 Jun; 20(11):1563-74. PubMed ID: 11391688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of information analysis optimizing future trial design from a pilot study on catheter securement devices.
    Tuffaha HW; Reynolds H; Gordon LG; Rickard CM; Scuffham PA
    Clin Trials; 2014 Dec; 11(6):648-56. PubMed ID: 25084784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials.
    Diehr P; Chen L; Patrick D; Feng Z; Yasui Y
    Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal clinical trial design using value of information methods with imperfect implementation.
    Willan AR; Eckermann S
    Health Econ; 2010 May; 19(5):549-61. PubMed ID: 19399753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental net benefit in the analysis of economic data from clinical trials, with application to the CADET-Hp trial.
    Willan AR
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):543-9. PubMed ID: 15167155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size estimation: an overview with applications to orthodontic clinical trial designs.
    Pandis N; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2011 Oct; 140(4):e141-6. PubMed ID: 21967951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical decision making and the expected value of information.
    Willan AR
    Clin Trials; 2007; 4(3):279-85. PubMed ID: 17715257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagram of reliability and net gain: a new method for summarizing and displaying the results of controlled trials.
    Cruccu G; Taylor RS
    Pain Pract; 2007 Sep; 7(3):230-3. PubMed ID: 17714101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incremental net benefit in randomized clinical trials with quality-adjusted survival.
    Willan AR; Chen EB; Cook RJ; Lin DY
    Stat Med; 2003 Feb; 22(3):353-62. PubMed ID: 12529868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach.
    Ramsey SD; Blough DK; Sullivan SD
    Med Care; 2008 May; 46(5):542-8. PubMed ID: 18438203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.